SCOPUS 정보 검색 플랫폼

International Journal of Immunopharmacology

Volumn 22, Issue 12, 2000, Pages 1077-1081

Anticancer drugs plus cytokines: Immunodulation based therapies of mouse tumors

(2) Mihich, E a Ehrke, M J a

a ROSWELL PARK CANCER INSTITUTE (United States)

Author keywords

Anticancer drugs; Cytokines; Tumors

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYTOKINE; DOXORUBICIN; INTERLEUKIN 1; INTERLEUKIN 2; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER SURVIVAL; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DOSE RESPONSE; IMMUNOLOGICAL MEMORY; IMMUNOMODULATION; LYMPHOMA; MACROPHAGE ACTIVATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; CYTOKINES; MICE; NEOPLASMS, EXPERIMENTAL;

EID: 0034535430 PISSN: 01920561 EISSN: None Source Type: Journal
DOI: 10.1016/S0192-0561(00)00072-2 Document Type: Article

Times cited : (17)

References (29)

1
- 0006748956
- Natl Cancer Monogr 63, September 1983; NIH Publication No. 83-2606, U.S. Dept. of Health and Human Services, NCI, Bethesda, MD
- Biological Response Modifiers: Subcommittee Report
- Mihich, E.¹ Fefer, A.²

2
- 0025147441
- Treatment of metastatic melanoma with an autologous tumor-cell vaccine: Clinical and immunologic result in 64 patients
- (1990) J Clin Oncol , vol.8 , pp. 1858-1867
- Berd, D.¹ McGuire H.C., Jr.² McCue, P.³ Mastrangelo, M.J.⁴

3
- 0002733046
- The role of cytokines in tumour rejection
- Dalgleish A, Browning R, editors. Tumour Immunology. Cambridge: Cambridge University Press
- (1996) , pp. 199-218
- Forni, G.¹ Foa, R.²

4
- 0006693059
- Cytokines and tumor immunogenicity: Toward an appropriate cancer vaccine
- Mihich E, Croce C, editors. The Biology of Tumors. New York: Plenum Press
- (1998) , pp. 231-247
- Cavallo, F.¹ Boggio, K.² Giovarelli, M.³ Forni, G.⁴

5
- 0001927235
- Immunotherapy by active specific immunization: Basic principles and preclinical studies
- DeVita VT, Hellman S, Rosenberg SA, editors. Biologic Therapy of Cancer. Philadelphia: JB Lippincott
- (1991) , pp. 651-669
- Hanna M.G., Jr.¹ Peters, L.C.² Hoover H.C., Jr.³

6
- 0031978249
- Immunotherapy of cancer with dendritic-cell-based vaccines
- (1998) Cancer Immunol Immunother , vol.46 , pp. 82-87
- Gilboa, E.¹ Nair, S.K.² Lyerly, H.K.³

7
- 0006688512
- Clinical applications of monoclonal antibodies in cancer: Melanoma
- De Vita VT, Hellman S, Rosenberg SA, editors. Biologic Therapy of Cancer, 2nd edition. Philadelphia: J.B. Lippincott
- (1995) , pp. 576-590
- Houghton, A.N.¹ Chapman, P.B.²

8
- 0001492403
- Combination cytokine therapy
- DeVita VT, Hellman S, Rosenberg SA, editors. Biologic Therapy of Cancer, 2nd edition. Philadelphia: J.B. Lippincott
- (1995) , pp. 443-466
- Atkins, M.B.¹ Mier, J.W.² Trehu, E.G.³

9
- 0001628533
- Cell transfer therapy: Clinical applications
- DeVita VT, Hellman S, Rosenberg SA, editors. Biologic Therapy of Cancer, 2nd Edition. Philadelphia: J.B. Lippincott
- (1995) , pp. 487-521
- Rosenberg, S.A.¹

10
- 0033643472
- Historical overview of biologic response modifiers
- (2000) Cancer Invest , vol.18 , pp. 456-466
- Mihich, E.¹

11
- 0006648513
- Immunology and cancer therapy: Present status and future projections
- Goldfarb R, Whiteside T, editors. Tumor Immunology and Cancer Therapy. New York: Marcel Dekker
- (1993) , pp. 293-310
- Mihich, E.¹

12
- 0001670797
- Immunopharmacology of anticancer agents
- Hadden JW, Szentivanyi A, editors. Immunopharmacology Reviews. New York: Plenum
- (1996) , pp. 103-127
- Ehrke, M.J.¹ Mihich, E.²

13
- 4243273303
- Drug selectivity in the suppression of the immune response
- Turk JL, Parker D, editors. Drugs and Immune Responsiveness. London: Macmillan
- (1979) , pp. 25-39
- Mihich, E.¹

14
- 0006751498
- Immunosuppressive agents
- Sartorelli AC, Johns DG, editors. Antineoplastic and Immunosuppressive Agents I. New York: Springer-Verlag
- (1974) , pp. 577-617
- Hersh, E.M.¹

15
- 0002303262
- Immunomodulation by anticancer drugs
- DeVita VT, Hellman S, Rosenberg SA, editors. Biologic Therapy of Cancer. Philadelphia: JB Lippincott
- (1991) , pp. 776-786
- Mihich, E.¹ Ehrke, M.J.²

16
- 0014649984
- Modification of tumor regression by immunologic means
- (1969) Cancer Res , vol.29 , pp. 2345-2352
- Mihich, E.¹

17
- 0030806768
- Taxol, a microtubule-stabilizing antineoplastic agent, differentially regulates normal and tumor-bearing host macrophage nitric oxide production
- (1997) Immunopharmacology , vol.37 , pp. 63-73
- Mullins, D.W.¹ Alleva, D.G.² Burger, C.J.³ Elgert, K.D.⁴

18
- 0024405229
- Effects of anticancer drugs on the immune system in man
- (1989) Semin Oncol , vol.16 , pp. 230-253
- Ehrke, M.J.¹ Mihich, E.² Berd, D.³ Mastrangelo, M.⁴

19
- 0021150594
- Adriamycin and other anthracyclines
- Mitchell MS, Fahey JL, editors. Clinics and Immunology and Allergy, Immune Suppression and Modulation, London: Saunders
- (1984) , vol.4 , pp. 259-277
- Ehrke, M.J.¹ Mihich, E.²

20
- 0024820729
- Modulations of antitumor immune effectors by Adriamycin
- Torisu M, Yoshida T, editors. Proc Int Symposium on New Horizons in Tumor Immunotherapy. Elsevier: Amsterdam
- (1989) , pp. 467-475
- Ehrke, M.J.¹ Ho, R.L.X.² Mihich, E.³

21
- 0001146824
- Doxorubicin (DOX)-induced immunomodulation of murine peritoneal exudate cells (PECs): Effect on cytokine mRNA levels and secreted protein
- (1997) Proc AACR , vol.38 , pp. 119
- Berleth, E.¹ Ujhazy, P.² Henn, A.³ Meer, J.⁴ Dolnick, B.⁵

22
- 0028033493
- Intracellular doxorubicin kinetics in lymphoma cells and lymphocytes infiltrating the tumor area in vivo: A flow cytometric study
- (1994) Oncol Res , vol.6 , Issue.4-5 , pp. 183-194
- Zaleskis, G.¹ Ho, R.X.L.² Diegelman, P.³ Maccubbin, D.⁴ Ujhazy, P.⁵

23
- 0027892990
- Development of a safe and effective Adriamycin plus interleukin 2 therapy against both Adriamycin sensitive and resistant lymphomas
- (1993) Oncol Res , vol.5 , pp. 373-381
- Ho, R.L.X.¹ Maccubbin, D.² Zaleskis, G.³ Krawczyk, C.⁴ Wing, K.⁵

24
- 0027849596
- Immunological responses critical to the therapeutic effects of Adriamycin plus interleukin 2 in C57BL/6 mice bearing syngeneic EL4 lymphoma
- (1993) Oncol Res , vol.5 , pp. 363-372
- Ho, R.L.X.¹ Maccubbin, D.² Ujhazy, P.³ Zaleskis, G.⁴ Eppolito, C.⁵

25
- 0029953959
- Demonstration of long-term specific anti-primary EL4 lymphoma immunity in 2-year old cured mice
- (1996) Cancer Immunol Immunother , vol.42 , Issue.4 , pp. 221-230
- Ehrke, M.J.¹ Verstovek, S.² Zaleskis, G.³ Ho, R.L.X.⁴ Ujhazy, P.⁵

26
- 0031960216
- Thymic effectors in chemoimmunotherapy cured mice: Phenotypic and functional characterization up to 20 months after initial tumor inoculation
- (1998) Intl J Cancer , vol.76 , pp. 579-586
- Ehrke, M.J.¹ Verstovsek, S.² Krawczyk, C.M.³ Ujhazy, P.⁴ Zaleskis, G.⁵

27
- 0031911609
- Doxorubicin plus tumor necrosis factor-( combination treatments in EL4 lymphoma-bearing C57BL/6 mice
- (1998) Cancer Immunol Immunother , vol.45 , Issue.6 , pp. 287-298
- Ehrke, M.J.¹ Verstovsek, S.² Ujhazy, P.³ Meer, J.M.⁴ Eppolito, C.⁵

28
- 0034129921
- Protective specific immunity induced by doxorubicin plus TNF-α combination treatment of EL4 lymphoma-bearing C57BL/6 mice
- (2000) Int J Cancer , vol.87 , pp. 101-109
- Ehrke, M.J.¹ Verstovsek, S.² Maccubbin, D.L.³ Ujhazy, P.⁴ Zaleskis, G.⁵

29
- 0028810937
- Cyclophosphamide plus tumor necrosis factor-α chemoimmunotherapy cured mice: Life-long immunity and rejection of reimplanted primary lymphoma
- (1995) Int J Cancer , vol.63 , Issue.3 , pp. 463-471
- Ehrke, M.J.¹ Verstovsek, S.² Krawczk, C.M.³ Ujhazy, P.⁴ Zaleskis, G.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.